| Dr Elizabeth Zaragoza, MD | |
|
Apartado 14457 Bo. Obrero Station, Santurce, PR 00916 | |
| (787) 726-7373 | |
| (787) 268-3249 |
| Full Name | Dr Elizabeth Zaragoza |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Adolescent Medicine |
| Location | Apartado 14457 Bo. Obrero Station, Santurce, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982754255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080A0000X | Pediatrics - Adolescent Medicine | 9833 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Zaragoza, MD Guadalquivir 135 El Paraiso, San Juan, PR 00926 Ph: (787) 250-0064 | Dr Elizabeth Zaragoza, MD Apartado 14457 Bo. Obrero Station, Santurce, PR 00916 Ph: (787) 726-7373 |
News Archive
The risk of 11 to 16-year-olds taking up smoking has reduced following the introduction of a ban on the open display of tobacco products in the UK, according to a new University of Stirling study.
Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) have found.
Meda has acquired exclusive US, Canadian and Japanese rights for the use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals. As part of the agreement, Meda is taking over full responsibility for development and commercialization of the compound. Flupirtine is currently in phase II development for the patented indication fibromyalgia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today presented additional interim data from its ongoing Phase I trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement. The data were presented at the Chemotherapy Foundation Symposium being held in New York City.
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug's reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest.
› Verified 7 days ago
Maria Elena Echevarria-escudero, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 252 San Jorge St, Suite 504, Santurce, PR 00912 Phone: 787-728-1575 Fax: 787-726-0402 | |
Dr. Otto L Aldahondo, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 258 Calle San Jorge, San Jorge Medical Building Suite 205, Santurce, PR 00912 Phone: 787-727-1000 Fax: 787-727-6550 | |
Leonardo Rafael Hormaza, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 253 Calle San Jorge, Suie 2b, Santurce, PR 00912 Phone: 787-999-9450 | |
Dr. Melvin A Bonilla-felix, M. D. Pediatrics Medicare: Medicare Enrolled Practice Location: 252 Calle Convento, Santurce, PR 00912 Phone: 787-726-1113 | |
Dr. Antoliano Torres Rodriguez, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1452 Calle Americo Salas, Esq. Pavia, Santurce, PR 00909 Phone: 787-722-1460 Fax: 787-726-5223 | |
Dr. Jose Ramon Colon - Leon, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Calle Victoria, 1559 1-b, Santurce, PR 00912 Phone: 787-724-7759 Fax: 787-724-7766 | |
Dr. Edgardo Alberty, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Americo Salas 1452, Santurce, PR 00909 Phone: 787-725-6297 Fax: 787-724-6490 |